University of
暂无分享,去创建一个
A. Gimenez-Roqueplo | J. Favier | D. Tennant | M. Janin | C. Lussey-Lepoutre | Luis J. Castro-Vega | Cosimo Martinelli | M. Ménara | Kate E. R. Hollinshead | Aurélie Morin | Christian Ludwig | Seth J. Parker | Chris Ottolenghi | Christian Metallo | Daniel A. Tennant | Christian Ludwig | Seth J. Parker | Chris Ottolenghi | Christian Metallo
[1] Xiaoyu Liang,et al. Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors. , 2015, Cancer research.
[2] Christian Frezza,et al. Defects in mitochondrial metabolism and cancer , 2014, Cancer & metabolism.
[3] W. Young,et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.
[4] Adam M. Feist,et al. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. , 2014, Molecular cell.
[5] A. Harris,et al. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer , 2014, Oncogene.
[6] Tomoyoshi Soga,et al. Oncometabolites: linking altered metabolism with cancer. , 2013, The Journal of clinical investigation.
[7] P. Bénit,et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. , 2013, Cancer cell.
[8] P. Szlosarek,et al. Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells , 2013, Cancer & metabolism.
[9] Jesse M. Platt,et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.
[10] Christian M. Metallo,et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.
[11] W. Marston Linehan,et al. Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.
[12] V. Orekhov,et al. Analysis of non-uniformly sampled spectra with multi-dimensional decomposition. , 2011, Progress in nuclear magnetic resonance spectroscopy.
[13] Christian Ludwig,et al. MetaboLab - advanced NMR data processing and analysis for metabolomics , 2011, BMC Bioinformatics.
[14] Gabriela Kalna,et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.
[15] A. Vénisse,et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. , 2011, Human molecular genetics.
[16] V. Orekhov,et al. Accelerated NMR spectroscopy by using compressed sensing. , 2011, Angewandte Chemie.
[17] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[18] P. Bénit,et al. SDHA is a tumor suppressor gene causing paraganglioma. , 2010, Human molecular genetics.
[19] P. Bénit,et al. The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas , 2009, PloS one.
[20] S. Gygi,et al. SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma , 2009, Science.
[21] E. Baudin,et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. , 2007, The Journal of clinical endocrinology and metabolism.
[22] Ying Zhang,et al. HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..
[23] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[24] B. Baysal. On the association of succinate dehydrogenase mutations with hereditary paraganglioma , 2003, Trends in Endocrinology & Metabolism.
[25] P. Hogendoorn,et al. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology , 2003, The Journal of pathology.
[26] P. Rustin,et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.
[27] I. Tomlinson,et al. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase , 2003, Annals of medicine.
[28] P. Rustin,et al. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.
[29] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[30] E S Husebye,et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.
[31] Ulrich Müller,et al. Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.
[32] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[33] H. Brunengraber,et al. Correction of 13C mass isotopomer distributions for natural stable isotope abundance. , 1996, Journal of mass spectrometry : JMS.
[34] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[35] 이연수. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .
[36] Pierre-François Plouin,et al. [COMETE, a network for the study and management of hypersecreting adrenal tumors]. , 2008, Bulletin de l'Academie nationale de medecine.
[37] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[38] B. Meier,et al. Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .